HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ali T Taher Selected Research

Chelation Therapy (Therapy, Chelation)

11/20212021 update on clinical trials in β-thalassemia.
11/2021Luspatercept for β-thalassemia: beyond red blood cell transfusions.
7/2020Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation.
7/2020A Report on the Education, Employment and Marital Status of Thalassemia Patients from a Tertiary Care Center in the Middle East.
1/2019Thalassemia and malignancy: An emerging concern?
11/2018Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias.
10/2018Iron overload in patients with myelodysplastic syndromes: An updated overview.
1/2018Deferasirox: Over a Decade of Experience in Thalassemia.
12/2017Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.
1/2016Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ali T Taher Research Topics

Disease

53Thalassemia
06/2022 - 01/2006
44Iron Overload
11/2021 - 01/2009
23beta-Thalassemia (Cooley's Anemia)
07/2020 - 09/2006
13Anemia
11/2021 - 07/2006
12Thrombosis (Thrombus)
08/2021 - 01/2004
9Sickle Cell Anemia (Hemoglobin S Disease)
06/2022 - 12/2009
6Infections
01/2016 - 01/2004
5Neoplasms (Cancer)
01/2022 - 04/2012
5Hemolytic Anemia
09/2020 - 07/2006
5Osteoporosis
01/2018 - 09/2006
4COVID-19
01/2022 - 01/2020
4Thrombophilia
07/2021 - 11/2012
4Hepatitis C
01/2018 - 07/2008
4Venous Thromboembolism
01/2018 - 12/2008
4Hemorrhage
01/2018 - 09/2007
4Siderosis
01/2017 - 01/2011
3Disease Progression
06/2022 - 01/2008
3Venous Thrombosis (Deep-Vein Thrombosis)
01/2022 - 09/2008
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
03/2021 - 01/2020
3Pain (Aches)
01/2020 - 09/2006
3Nausea
03/2016 - 08/2012
3Leg Ulcer
12/2014 - 03/2010
3Hypothyroidism
07/2012 - 03/2010
3Hypogonadism (Hypergonadotropic Hypogonadism)
07/2012 - 03/2010
3Budd-Chiari Syndrome (Budd Chiari Syndrome)
08/2010 - 10/2005
2Hemoglobinopathies
05/2022 - 01/2018
2Pulmonary Embolism
01/2022 - 10/2010
2Diamond-Blackfan Anemia (Anemia, Diamond Blackfan)
08/2020 - 12/2009
2Arthralgia (Joint Pain)
01/2020 - 03/2011
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2018 - 05/2017
2Heart Failure
01/2018 - 03/2010
2Fatigue
01/2018 - 07/2014
2Proteinuria
12/2017 - 01/2012
2Exanthema (Rash)
01/2017 - 08/2012
2Abdominal Pain (Pain, Abdominal)
07/2014 - 03/2008
2Priapism
01/2014 - 11/2013
2Seizures (Absence Seizure)
08/2013 - 07/2009
2Essential Thrombocythemia
06/2013 - 08/2010
2Pulmonary Hypertension
04/2012 - 11/2011
2Thrombocytopenia (Thrombopenia)
03/2012 - 07/2006
2Hemolysis
01/2012 - 01/2004
2Hemophilia A (Haemophilia)
12/2010 - 09/2007
2Multiple Myeloma
03/2009 - 06/2007
2Cardiovascular Diseases (Cardiovascular Disease)
09/2008 - 06/2006
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
01/2022
1Hypohidrosis
01/2022
1Inflammation (Inflammations)
09/2021
1Musculoskeletal Diseases (Musculoskeletal Disease)
03/2021
1Sjogren's Syndrome (Sjogren Syndrome)
03/2021
1Habitual Abortion (Recurrent Miscarriage)
03/2021
1Systemic Scleroderma (Systemic Sclerosis)
03/2021
1Neonatal Alloimmune Thrombocytopenia
03/2021

Drug/Important Bio-Agent (IBA)

51IronIBA
11/2021 - 07/2008
17DeferasiroxFDA Link
01/2019 - 12/2009
16Hemoglobins (Hemoglobin)IBA
06/2022 - 12/2011
13GlobinsIBA
05/2022 - 01/2006
11Ferritins (Ferritin)IBA
01/2019 - 01/2009
7Chelating AgentsIBA
01/2018 - 01/2011
6Hydroxyurea (Hydrea)FDA LinkGeneric
01/2022 - 03/2010
6DeferiproneIBA
01/2016 - 01/2011
5Pharmaceutical PreparationsIBA
01/2018 - 06/2007
5Deferoxamine (Desferal)FDA LinkGeneric
01/2016 - 02/2012
4Fetal Hemoglobin (Hemoglobin F)IBA
06/2022 - 01/2012
4luspaterceptIBA
12/2021 - 01/2020
4Antiphospholipid AntibodiesIBA
08/2021 - 01/2020
4HepcidinsIBA
10/2018 - 04/2012
4factor V LeidenIBA
03/2015 - 10/2005
4Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
10/2010 - 01/2004
3LigandsIBA
12/2021 - 01/2019
3AntibodiesIBA
03/2021 - 07/2006
3TabletsIBA
01/2019 - 05/2017
3Prothrombin (Factor II)IBA
10/2010 - 01/2004
2Messenger RNA (mRNA)IBA
01/2022 - 01/2022
2AnticoagulantsIBA
07/2021 - 01/2018
2Intravenous Immunoglobulins (IVIG)FDA Link
03/2021 - 01/2004
2Phospholipids (Phosphatides)FDA LinkGeneric
03/2021 - 01/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 01/2014
2Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2021 - 11/2012
2Growth Differentiation Factor 15IBA
01/2017 - 12/2011
22,2-dimethylbutyric acidIBA
07/2014 - 11/2013
2Transferrin (beta 2 Transferrin)IBA
01/2012 - 12/2011
2Factor VIIa (Activated Factor VII)IBA
12/2010 - 09/2007
2Antiviral Agents (Antivirals)IBA
06/2010 - 10/2009
2Thalidomide (Thalomid)FDA Link
12/2009 - 06/2007
2Factor V (Coagulation Factor V)IBA
12/2008 - 04/2006
2Zoledronic Acid (Zometa)FDA Link
11/2008 - 09/2006
1AntioxidantsIBA
05/2022
1Activin Receptors (Activin Receptor)IBA
12/2021
1betibeglogene autotemcelIBA
10/2021
1Activins (Activin)IBA
10/2021
1Immunoglobulin A (IgA)IBA
09/2021
1Immunoglobulin G (IgG)IBA
03/2021
120-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
01/2021

Therapy/Procedure

24Therapeutics
11/2021 - 01/2004
22Chelation Therapy (Therapy, Chelation)
11/2021 - 01/2009
10Splenectomy
01/2019 - 12/2005
8Blood Transfusion (Blood Transfusions)
01/2019 - 01/2009
5Drug Therapy (Chemotherapy)
12/2009 - 01/2008
3Hematopoietic Stem Cell Transplantation
11/2021 - 01/2017
1Erythrocyte Transfusion
11/2021